A novel biomarker for non-alcoholic fatty liver disease has been discovered using transcriptomic analysis, paving way for non-invasive diagnostic procedures. With the rising prevalence of obesity,...
A study by researchers from the Dalian Institute of Chemical Physics of the Chinese Academy of Sciences have uncovered the underlying mechanism of how Y-box binding protein 1 promotes cancer...
A signalling protein thought to be able to treat liver damage in paracetamol toxicity could actually worsen it. Here, Singapore scientists discovered that blocking its effects could be the way...
A new study led by Maria Manuel Mota, group leader at Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal), now shows that malaria parasites secrete the protein EXP2 that is required...
Scientists from A*STAR’s Genome Institute of Singapore (GIS), Singapore Immunology Network (SIgN), National Cancer Centre Singapore (NCCS) and KK Women’s and Children’s Hospital (KKH) uncover...
A study of over 1,000 COVID-19 patients conducted by the Faculty of Medicine at the Chinese University of Hong Kong (CU Medicine) showed that around 20 percent of patients had liver injury and...
Scientists from China elucidate the function of the def gene for the first time. Hepatocytes are responsible for diverse metabolic activities in a liver. Proper ribosome biogenesis is essential to...
A new treatment approach involves blocking a protein - interleukin 11. A team of researchers led by Duke-NUS Medical School and National Heart Centre Singapore (NHCS) found that deactivating a...
New therapy approach points to potential treatment of liver cancer patients with hepatitis B virus infection. Chronic hepatitis B virus (HBV) infection is predominant in Asia and is highly associated...
